ZOLEDRONAT Teva onco 4 mg/5ml flac 5 ml
7680622000034
CH-62200
M05BA08
07.99.0.
1 / 3
google
Details
- Product number
- 6220001
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- acidum zoledronicum 4 mg ut acidum zoledronicum monohydricum, mannitolum, natrii citras dihydricus, aqua ad iniectabile ad solutionem pro 5 ml corresp. natrium 5.65 mg.
Articles (1)
Zoledronat-Teva onco 4 mg/ 5 ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
4.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
5.65 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 134.10
Specialties list
Yes
Generic
Yes
SL addition date:
01/06/2023
Authorization holder
Teva Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 62200
- Drug name
- Zoledronat-Teva onco, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- M05BA08
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 25/04/2012
- Authorization expiration date
- 31/12/9999
- IT number
- 07.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ZOLEDRONAT Teva onco 4 mg/5ml flac 5 ml
- Description (DE)
- ZOLEDRONAT Teva onco 4 mg/5ml Durchstf 5 ml
- Market launch
- 25/04/2012
- Narcotic (BTM)
- No